Jpmorgan Chase & Co »

Achieve Life Sciences shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Achieve Life Sciences (ACHV) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Achieve Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Achieve Life Sciences held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Achieve Life Sciences by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $71k 15k 4.74
2024-06-30 $69k 15k 4.70
2023-03-31 $1.7k 250 6.80

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Ser 1 S&p Common (SPY)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Unitedhealth Group Common (UNH)
Mastercard Incorporated Common (MA)
Vanguard Index Fds S&p 500 Etf Common (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard Total Intl Bond Etf Fund (BNDX)
Broadcom Common (AVGO)
Exxon Mobil Corp Common (XOM)

View all positions for Jpmorgan Chase & Co

Top funds holding Achieve Life Sciences

Franklin Resources
Propel Bio Management
BlackRock
BlackRock
Sofinnova Ventures
Vanguard Group
Geode Capital Management
Nantahala Capital Management
Alyeska Investment Group
Shay Capital
State Street Corporation
Northern Trust
Long Focus Capital Management
Simplify Asset Management
Altium Capital Management

View all funds holding Achieve Life Sciences